Precision cardiovascular medicine: global imperative for equity through innovation
-
By
-
Jose R. Medina-Inojosa
-
Fatima Rodriguez
-
Francisco Lopez-Jimenez
-
Laurence S. Sperling
-
July 13, 2026
Clinical Scorecard: Advancing Equity in Cardiovascular Care: The Global Need for Innovative Precision Medicine
At a Glance
| Category | Detail |
|---|
| Condition | Cardiovascular Disease (CVD) |
| Key Mechanisms | Precision medicine approaches including artificial intelligence, multiomics, and digital diagnostics. |
| Target Population | Low- and middle-income countries (LMICs) and historically underserved populations. |
| Care Setting | Global health systems focusing on equity-centered policies. |
Key Highlights
- CVD is the leading cause of death globally, particularly affecting LMICs.
- Precision medicine can transform CVD prevention and management.
- Equity-centered policies are essential to prevent exacerbating health disparities.
- The WHF proposes frameworks to operationalize equity in cardiovascular care.
- Access to precision tools is hindered by infrastructure and systemic barriers.
Guideline-Based Recommendations
Diagnosis
- Utilize precision medicine for early detection and treatment of CVD.
Management
- Implement system-level changes in policy, workforce, data, and workflow to support precision medicine.
Monitoring & Follow-up
- Leverage digital health tools for remote monitoring and follow-up.
Risks
- Without equity-focused strategies, precision medicine may widen existing health disparities.
Patient & Prescribing Data
Individuals in LMICs and underserved communities.
Precision approaches should be tailored to local contexts and patient realities.
Clinical Best Practices
- Incorporate diverse cohorts in research to enhance the applicability of precision medicine.
- Address social determinants of health alongside precision medicine initiatives.
- Foster collaborative data science to correct discovery bias and promote inclusive breakthroughs.
Related Resources & Content
